CLAiR Pivotal Study
- Age
- 40 – 75
- Sex
- Any
- Study type
- Observational
- Participants needed
- 942 (estimated)
- Sponsor
- Toku Eyes Ltd · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityThis is a multi-site, observational clinical study to validate the performance of the CLAiR AI software in identifying elevated atherosclerotic cardiovascular disease (ASCVD) risk from retinal (eye) images obtained from two different retinal image camera models.
Loading trial locations…